Lynx1 Capital Management Lp Top Holdings and 13F Report (2024) About Lynx1 Capital Management LpInvestment ActivityLynx1 Capital Management Lp has $282.24 million in total holdings as of September 30, 2024.Lynx1 Capital Management Lp owns shares of 18 different stocks, but just 5 companies or ETFs make up 80% of its holdings.Approximately 99.53% of the portfolio was purchased this quarter.This quarter, Lynx1 Capital Management Lp has purchased 1 new stock and bought additional shares in 1 stock.Lynx1 Capital Management Lp sold shares of 0 stocks and completely divested from 0 stocks this quarter.Largest Holdings Merus $89,621,545Stoke Therapeutics $63,750,577C4 Therapeutics $39,219,004GH Research $28,070,531TScan Therapeutics $26,018,508 Largest New Holdings this Quarter Merus $89,621,545 HoldingStoke Therapeutics $63,750,577 HoldingC4 Therapeutics $39,219,004 HoldingGH Research $28,070,531 HoldingTScan Therapeutics $26,018,508 Holding Largest Purchases this Quarter Merus 1,793,866 shares (about $89.62M)Stoke Therapeutics 5,187,191 shares (about $63.75M)C4 Therapeutics 6,880,527 shares (about $39.22M)GH Research 4,195,894 shares (about $28.07M)TScan Therapeutics 5,224,600 shares (about $26.02M) Sector Allocation Over TimeMap of 500 Largest Holdings ofLynx1 Capital Management Lp Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorMRUSMerus$89,621,545$89,621,545 ▲New Holding1,793,86631.8%MedicalSTOKStoke Therapeutics$63,750,577$63,750,577 ▲New Holding5,187,19122.6%MedicalCCCCC4 Therapeutics$39,219,004$39,219,004 ▲New Holding6,880,52713.9%MedicalGHRSGH Research$28,070,531$28,070,531 ▲New Holding4,195,8949.9%MedicalTCRXTScan Therapeutics$26,018,508$26,018,508 ▲New Holding5,224,6009.2%MedicalALLOAllogene Therapeutics$17,366,647$17,366,647 ▲New Holding6,202,3746.2%MedicalCGEMCullinan Therapeutics$6,877,294$6,877,294 ▲New Holding410,8302.4%MedicalPASGPassage Bio$5,898,869$5,898,869 ▲New Holding8,426,9552.1%MedicalIBIO INC$1,914,259$582,259 ▲43.7%862,2790.7%CON NEWCRBUCaribou Biosciences$1,333,170$1,333,170 ▲New Holding680,1890.5%MedicalKODKodiak Sciences$707,772$707,772 ▲New Holding271,1770.3%MedicalPIERIS PHARMACEUTICALS INC$620,689$620,689 ▲New Holding37,4360.2%COM NEWCNTACentessa Pharmaceuticals$278,226$278,226 ▲New Holding17,4000.1%MedicalBNOXBionomics$241,471$241,471 ▲New Holding549,6730.1%MedicalKINIKSA PHARMACEUTICALS INTL$205,693$205,693 ▲New Holding8,2310.1%ORD SHS CL ATENAX THERAPEUTICS INC$51,038$51,038 ▲New Holding14,7510.0%COM NEWIPSCCentury Therapeutics$32,538$32,538 ▲New Holding19,0280.0%MedicalVYNEVYNE Therapeutics$30,445$30,445 ▲New Holding16,1940.0%MedicalShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
